Alberto Dolci, MD
Clinical Chemistry Laboratory, Hospital “Luigi Sacco”, Milan, Italy

Roberto Dominici, MD
Clinical Chemistry Laboratory, Hospital “Luigi Sacco”, Milan, Italy

Daniela Cardinale, MD
Cardiology Unit, European Institute of Oncology, Milan, Italy

Maria T. Sandri, MD
Laboratory Medicine Unit, European Institute of Oncology, Milan, Italy

Mauro Panteghini, MD
Clinical Chemistry Laboratory, Hospital “Luigi Sacco”, Milan, Italy
Department of Clinical Sciences “Luigi Sacco”, University of Milan, Milan, Italy

Keywords: Cardiotoxicity; Chemotherapy; Troponin; Cardiac natriuretic peptides; Congestive heart failure; Left ventricular dysfunction; Biomarkers

Upon completion of this activity, you will be able to:

• define the most effective biochemical strategy to predict chemotherapy-induced cardiotoxicity in clinical practice.
• apply an evidence-based approach to biomarker utilization.
• examine the clinical evidence derived from published studies.